Category Archives: by Gus Gardner

ISPOR Asia-Pacific: Uniting to Create Impactful Change

Life sciences researchers, thought leaders and industry colleagues gathered in Singapore in early September to discuss the status of pharmacoeconomics and outcomes research in the Asia-Pacific region. The 7th ISPOR Asia-Pacific conference presented an opportunity to concentrate on the issues particular to this unique and diverse part of the world in an effort to achieve […]
Read More »

Identifying population risk in new members requires aggregated health status data

As new enrollees enter the market from public exchanges and expanded Medicaid programs, health plans must determine how to appropriately assess member health in order to align interventions and better predict costs. Doing so effectively, however, requires having access to as much information as possible. A combination of multiple data sets — including claims-based data […]
Read More »